Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 753 of 6351
-
New hope for Tough-to-Treat blood cancer: phase 3 trial launches
Disease control OngoingMultiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Personalized immunotherapy shows promise for advanced melanoma in new trial
Disease control Recruiting nowThe purpose of this study is to determine if neoadjuvant (treatment before surgery) immunotherapy treatment based on tumor biomarkers results in better participant outcomes. Immunotherapy is the treatment of disease by using a person's own immune system. This study is divided in…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug aims to stop brain bleeds in rare disease
Disease control OngoingThe purpose of the study is to evaluate the effect of ALN-APP on measures of CAA disease progression and to characterize the safety, tolerability, and pharmacodynamics (PD) of ALN-APP in adult patients with sporadic CAA (sCAA) and Dutch-type CAA (D-CAA). The study will be conduct…
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Blood biomarkers may foreshadow Radiation-Induced dry mouth
Diagnosis CompletedA large number of patients undergoing radiotherapy and chemotherapy are suffering from dry mouth. Due to reduced saliva secretion, patients may experience symptoms such as difficulty chewing and swallowing. In severe cases, they may also experience pain and burning sensation in t…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Could a cancer drug help cure hepatitis b? new trial launches
Disease control OngoingThis is a prospective, open-labled, randomized controlled study to assess efficacy and safety of treatment with Sintilimab (PD-1 antibody) combined Peg-IFNα-2b in CHB patients on stable NAs treatment.
Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Sound waves aimed at the brain may unstick Parkinson's freezing
Symptom relief Recruiting nowThis study is investigating the use of transcranial ultrasound stimulation (TUS) on the Pedunculopontine nucleus (PPN) in changing freezing of gait in people with Parkinson's disease. The PPN is noted to be involved in voluntary movements, locomotion, and muscle tone. This will b…
Sponsor: Robert Chen • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can a booster for the immune system tame a Slow-Moving lung fungus?
Disease control OngoingThis study explores the role of treatment with interferon-gamma to improve outcomes in chronic pulmonary aspergillosis (CPA). CPA is a progressive infection caused by the fungus Aspergillus affecting patients with chronic lung disease like Chronic Obstructive Lung Disease (COPD) …
Phase 2 • Sponsor: Manchester University NHS Foundation Trust • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
A simple blood test may predict leukemia treatment success
Diagnosis Recruiting nowAcute myeloid leukemia (AML) is a malignant disorder of the bone marrow and the most common form of acute leukemia in adults. Patient with AML have the shortest survival compared to other forms of leukemia. In the past 6 years, several new therapies have been approved. Biomarker…
Sponsor: Suhu Liu • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New pill could melt away heart disease plaque, major trial underway
Disease control OngoingThis placebo-controlled, double-blind, randomized, Phase 3 study is being conducted in adult participants with high-risk atherosclerotic cardiovascular disease (ASCVD) who are not adequately controlled by their maximally tolerated lipid-modifying therapy, to assess the impact of …
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for aggressive lung cancer: drug cocktail plus Low-Dose radiation shows promise
Disease control OngoingPhase Ib/II, open-label, multicentre study to evaluate the efficacy and safety of low-dose radiotherapy (LDRT) combined with AK104 and chemotherapy as first-line treatment for patients with ES-SCLC.
Phase 1/2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can CBD capsules help you sleep? large trial seeks answers
Symptom relief OngoingInsomnia is a common sleep disorder in which a person has difficulty falling asleep or staying asleep or getting good quality sleep. Consequences of insomnia include daytime sleepiness, poor memory function, decline in concentration with negative impacts on social and work activi…
Phase 3 • Sponsor: Avecho Biotechnology • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Zapping prostate tumors without major side effects: new trial launches
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of Irreversible Electroporation (IRE) using NanoKnife technology in patients with intermediate-risk prostate cancer. This patient population was chosen because they would otherwise be treated with conventio…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Radiation plus hormone therapy may slow resistant prostate cancer
Disease control Recruiting nowThe objectives of the study are to analyze the results obtained in survival, safety and quality of life after the combination of SBRT plus second-generation antiandrogen in patients diagnosed with metastatic castration-resistant prostate cancer in oligometastasis (≤5). Hence, th…
Phase 2 • Sponsor: Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a care program cut recovery time after gynecologic surgery?
Disease control Recruiting nowEnhanced Recovery After Surgery (ERAS) is a multidisciplinary perioperative care program designed to reduce surgical stress, accelerate postoperative recovery, and improve clinical outcomes. This prospective, non-randomized study aims to evaluate the effectiveness of an ERAS prog…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a simple supplement boost IVF success in PCOS?
Disease control CompletedPolycystic ovary syndrome (PCOS) is a common endocrine disorder that may affect ovarian function, insulin sensitivity, and fertility. Myo-inositol has been proposed as an insulin-sensitizing supplement that may improve metabolic and reproductive outcomes in women with PCOS. This…
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug shows promise for rare blood vessel disease
Disease control OngoingRACEMATE is a phase 2b, multicentre, randomised, double-blinded, placebo-controlled study designed to explore the efficacy and mechanism of action of tezepelumab in adults with eosinophilic granulomatosis with polyangiitis (EGPA).
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New shot could ease painful skin condition
Disease control CompletedThis is a study to evaluate the clinical efficacy and safety of sonelokimab administered subcutaneously compared with placebo in the treatment of adult participants with moderate to severe hidradenitis suppurativa. Participants will be randomized 2:1 to either sonelokimab or matc…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can smartphone sensing boost depression care for new mothers in nepal?
Symptom relief CompletedIn certain low- and middle- income country settings, there is a disproportionate level of untreated postpartum depression that presents both acute and long-term risks to a mother's well-being. Although there is increasing willingness among health systems to involve non-specialist…
Sponsor: George Washington University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Engineered immune cells take on tough gut cancers in new trial
Disease control Recruiting nowThe goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least 1 standard treatment regimen in the metastatic or locally advanced setting.
Phase 1/2 • Sponsor: Chimeric Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Light therapy takes aim at tough pancreatic tumors
Disease control Recruiting nowThis is a prospective, multicenter, non-randomized, open label light dose escalation phase I trial to evaluate the safety and preliminary efficacy of Padeliporfin vascular targeted photodynamic therapy (VTP) applied via endovascular fiber placement within a dilatation catheter, t…
Phase 1 • Sponsor: Impact Biotech Ltd • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC